Amends the Illinois Controlled Substances Act. Provides that each prescriber or the prescriber's designee shall document an attempt to access patient information in the Prescription Monitoring Program to assess patient access to controlled substances when providing a (rather than an initial) prescription for Schedule II and IV controlled substances (rather than narcotics such as opioids), except for prescriptions for oncology treatment or palliative care, or a 7-day or less supply provided by a hospital emergency department when treating an acute, traumatic medical condition.
House Committee Amendment No. 1: Replaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Provides that a prescriber is not subject to civil or criminal liability or professional discipline for failure to register with the Prescription Monitoring Program due to technological or electrical failures or operational issues that prevent registration. Provides that each prescriber or the prescriber's designee shall document an attempt to access patient information in the Prescription Monitoring Program to assess patient access to controlled substances when providing an initial prescription for any stimulant substances listed in Schedule II and all prescriptions (rather than an initial prescription) for Schedule II opioids and Schedule IV benzodiazepine (rather than Schedule II narcotics, such as opioids). Provides that a prescriber is not subject to criminal (rather than civil or criminal) liability or professional discipline for failure to register with the Prescription Monitoring Program due to technological or electrical failures or operational issues that prevent registration.

Statutes affected:
Introduced: 720 ILCS 570/314